Menu
Not yet recruiting NCT07559448

Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis

No phase Interventional Chronic Pancreatitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Palatable Elemental Diet.
Who it may be relevant to
Registry conditions: Chronic Pancreatitis. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Feasibility of a Novel Oral Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis

Overview

The goal of this clinical trial is to learn whether a 2-week exclusive palatable elemental diet is feasible, tolerable, and acceptable for adults with chronic pancreatitis and bothersome gastrointestinal symptoms. An elemental diet is a nutritionally complete formula made from ingredients that are easy to absorb. The main questions it aims to answer are whether participants can complete the diet as planned, and whether they can take in most of the prescribed formula, and how acceptable the study diet is to participants at the end of the 2-week diet period.

Interventions

  • Other Palatable Elemental Diet
    The intervention is an exclusive oral palatable elemental diet administered for 14 consecutive days as the participant's sole nutritional intake. This amino acid-based formula was developed to provide an elemental diet with improved palatability and tolerability. Following completion of the 14-day diet period, participants will return to their usual diet and undergo 4 additional weeks of follow-up.

Primary outcome measures

  • Number of Participants Who Complete at Least 12 of 14 Days of the Palatable Elemental Diet [Time frame: During the 14-day exclusive palatable elemental diet period (Day 14 to Day 28)]
  • Number of Participants Who Consume at Least 75% of Prescribed Palatable Elemental Diet Calories [Time frame: During the 14-day exclusive palatable elemental diet period (Day 14 to Day 28)]
Secondary outcome measures (3)
  • Participant-Reported Acceptability of the Palatable Elemental Diet [Time frame: Day 28, after completion of the 14-day exclusive palatable elemental diet period]
  • Change From Baseline in Structured Assessment of Gastrointestinal Symptoms Global Symptom Burden Score [Time frame: Baseline, Day 28, and Day 56]
  • Change From Baseline in Patient-Reported Outcomes Measurement Information System Global Health Version 1.2 (PROMIS Global Health v1.2) Summary Score [Time frame: Baseline, Day 28, and Day 56]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 to 75 years
  • Clinical diagnosis of chronic pancreatitis based on medical history and study physician assessment
  • Self-reported chronic pancreatitis-related gastrointestinal symptoms within 30 days before enrollment, with significant global gastrointestinal symptom burden defined as a Structured Assessment of Gastrointestinal Symptoms (SAGIS) score of 16 or higher

Exclusion criteria

  • Pancreatic tumor or pancreatic cancer
  • History of pancreatic surgery
  • Pregnancy or breastfeeding
  • Diagnosis of a condition other than chronic pancreatitis that contributes to gastrointestinal symptoms, based on medical history or study physician assessment
  • Active infection or antibiotic use within the last month
  • History of phenylketonuria
  • Insulin-dependent diabetes or diabetes requiring insulin treatment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Stanford Digestive Health Care Center — Redwood City

Identifiers

NCT: NCT07559448 · 84595

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗